In this episode of "Twinning Strategy," the team discusses tips on attracting press coverage and funding. Learn how to find the right time to start PR, craft compelling stories that journalists (and investors) crave, and even turn crises into positive opportunities.

Launching a new robotics solution is always a challenge. It's highly technical and can be difficult to translate for a general audience. That's why OSARO partnered with ZingPR to craft a compelling media strategy. Instead of focusing on specs, we highlighted the real-world benefits: warehouse safety and efficiency.

rBIO's biosimilar insulin story landed in Wired, MedCity News, and more. See the PR tactics that drove success and get tips for your biotech launch.

With its patented technology that can extend metalens field of view (FOV) to almost 180 degrees without sacrificing imaging quality, 2Pi Optics outperforms conventional wide-FOV refractive optics in size, weight, performance, and cost.

CureLab Oncology’s DNA vaccine Elenagen, in combination with a proven chemotherapy, demonstrates promising clinical results against one of the deadliest forms of ovarian cancer.

It’s incredibly important to have a strong brand image and supporting story before you begin PR. Here are some of our recent branding and website success stories with some hugely promising science startups.

Gero is a cutting-edge biotechnology company dedicated to the mission of curing age-related human diseases and understanding, slowing, and even halting the aging process itself.

By adopting the Optellum Virtual Nodule Clinic, the Interventional Pulmonology team at AtlantiCare's Lung Nodule Clinic, led by Amit Borah, M.D., interventional pulmonologist, can focus on identifying and systematically following up on patients with incidentally detected lung nodules.

Cyclica will apply its AI-enabled drug discovery platform to discover new therapeutic options with the goal of expanding the range of accessible non-hormonal contraceptive choices for women in developing countries.

Two biotech leaders have embarked on a research project to streamline manufacturing of non-viral CRISPR gene editing components. Their goal is to improve the editing efficiency and cell viability of non-viral-based cell therapies.

The clinical benefits currently delivered for terminally ill patients in CureLab’s clinical trial are already exceeding the benefits of new drugs recently approved by the FDA.

LumaPay™ enables patients to pay their bills right from text messages or their providers' websites. The announcement is part of a broader repositioning of Luma's focus on patient success.

GenScript’s new GMP-grade GenExact™ single-stranded DNA (ssDNA) and GenWand™ closed-end linear double-stranded DNA (dsDNA) services enable new workflows

Allelica and Invitae want to integrate lifesaving genomic information into breast cancer risk assessments — for the benefit all women

Brickit uses clever AI to help kids build new creations with their LEGO bricks — and scores some super coverage across tech and consumer media.

Opalia hits a key go-to-market milestone by eliminating fetal bovine serum from its cell-based milk manufacturing process